Terms: = Kidney tumors AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
85 results:
1. TGMIL: A hybrid multi-instance learning model based on the Transformer and the Graph Attention Network for whole-slide images classification of renal cell carcinoma.
Sun X; Li W; Fu B; Peng Y; He J; Wang L; Yang T; Meng X; Li J; Wang J; Huang P; Wang R
Comput Methods Programs Biomed; 2023 Dec; 242():107789. PubMed ID: 37722310
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of cMYC-max transcription factors hetero-dimerization with structurally engineered omoMYC to downregulate oncogenic pathways in renal carcinoma.
Li W; Bano F; Khan A; Wei DQ; Alshammari A; Xu B; Wang Y
Comput Biol Med; 2023 Sep; 164():107257. PubMed ID: 37527610
[TBL] [Abstract] [Full Text] [Related]
3. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
Sarswat S; Khan D; Sagar S; Kumar R
Nucl Med Commun; 2023 Aug; 44(8):726-731. PubMed ID: 37272295
[TBL] [Abstract] [Full Text] [Related]
4. Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.
Chen WY; Thuy Dung PV; Yeh HL; Chen WH; Jiang KC; Li HR; Chen ZQ; Hsiao M; Huang J; Wen YC; Liu YN
Redox Biol; 2023 Jun; 62():102686. PubMed ID: 36963289
[TBL] [Abstract] [Full Text] [Related]
5. Early Postoperative Outcomes of Retroperitoneal Partial Nephrectomy of Anterior and Posterior Renal tumors: A 5-Year Experience in A Single Center.
Hsieh CC; Tseng WH; Liu CL; Su CC; Li CF; Ho CH; Huang SK; Chiu AW
J Endourol; 2023 May; 37(5):557-563. PubMed ID: 36927036
[No Abstract] [Full Text] [Related]
6. PCGF6/max/KDM5D facilitates MAZ/CDK4 axis expression and pRCC progression by hypomethylation of the DNA promoter.
Zhu M; Zhang RN; Zhang H; Qu CB; Zhang XC; Ren LX; Yang Z; Gu JF
Epigenetics Chromatin; 2023 Mar; 16(1):9. PubMed ID: 36890610
[TBL] [Abstract] [Full Text] [Related]
7. Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study.
Rossi E; Boldrini L; Maratta MG; Gatta R; Votta C; Tortora G; Schinzari G
Hum Vaccin Immunother; 2023 Dec; 19(1):2172926. PubMed ID: 36723981
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters.
Arikan R; Ozguven S; Telli TA; Isik S; Demircan NC; Basoglu T; Yasar A; Celebi A; Filizoglu N; Ustun HS; Tinay I; Ones T; Turoglu HT; Erdil TY; Ozturk MA; Ercelep O; Bayoglu V; Kostek O; Dane F; Yumuk PF
Acta Radiol; 2023 May; 64(5):2040-2049. PubMed ID: 36447438
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of 5 Fraction Stereotactic Body Radiation Therapy (SBRT) for Osseous Renal Cell Carcinoma Metastases.
Dove APH; Wells A; Gong W; Liu D; Kirschner AN
Am J Clin Oncol; 2022 Dec; 45(12):501-505. PubMed ID: 36413679
[TBL] [Abstract] [Full Text] [Related]
10. Interstitial Brachytherapy of the Liver for Renal Cell Carcinoma: ADC Measurements Do Not Predict Overall Survival.
Thormann M; Heitmann F; Wrobel V; March C; Pech M; Surov A; Damm R; Omari J
In Vivo; 2022; 36(6):2945-2951. PubMed ID: 36309358
[TBL] [Abstract] [Full Text] [Related]
11. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model.
Hardiansyah D; Riana A; Beer AJ; Glatting G
Z Med Phys; 2023 Feb; 33(1):70-81. PubMed ID: 35961809
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
[TBL] [Abstract] [Full Text] [Related]
13.
Gao J; Meng L; Xu Q; Zhao X; Deng Y; Fu Y; Guo S; He K; Shi J; Wang F; Zhang S; Guo H
Mol Imaging Biol; 2022 Oct; 24(5):759-768. PubMed ID: 35451707
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic importance of SUVmax values evaluated by 18F-FDG-PET/CT before nivolumab treatment in patients with metastatic renal cell carcinoma.
Gulturk I; Yilmaz M; Tacar SY; Tural D
Q J Nucl Med Mol Imaging; 2023 Sep; 67(3):223-229. PubMed ID: 34881845
[TBL] [Abstract] [Full Text] [Related]
15. The Influence of Wuzhi Capsule on the Pharmacokinetics of Cyclophosphamide.
Chen L; Ji N; Zhang M; Chen W
Recent Pat Anticancer Drug Discov; 2022; 17(2):195-203. PubMed ID: 34758719
[TBL] [Abstract] [Full Text] [Related]
16. The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancer.
Liao MZ; Prenen H; Dutta S; Upreti VV
Cancer Chemother Pharmacol; 2021 Oct; 88(4):665-672. PubMed ID: 34213592
[TBL] [Abstract] [Full Text] [Related]
17. Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study.
Nikolovski I; Carlo MI; Chen YB; Vargas HA
Cancer Imaging; 2021 Feb; 21(1):24. PubMed ID: 33608050
[TBL] [Abstract] [Full Text] [Related]
18.
Thakur S; Daley B; Millo C; Cochran C; Jacobson O; Lu H; Wang Z; Kiesewetter D; Chen X; Vasko V; Klubo-Gwiezdzinska J
Clin Cancer Res; 2021 Mar; 27(5):1399-1409. PubMed ID: 33355247
[TBL] [Abstract] [Full Text] [Related]
19. Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program.
Albiges L; Fléchon A; Chevreau C; Topart D; Gravis G; Oudard S; Tourani JM; Geoffrois L; Meriaux E; Thiery-Vuillemin A; Barthélémy P; Ladoire S; Laguerre B; Perrot V; Billard A; Escudier B; Gross-Goupil M
Eur J Cancer; 2021 Jan; 142():102-111. PubMed ID: 33253997
[TBL] [Abstract] [Full Text] [Related]
20. A polymeric paste-drug formulation for local treatment of upper tract urothelial carcinoma.
Kesch C; Schmitt V; Bidnur S; Thi M; Beraldi E; Moskalev I; Yago V; Bowden M; Adomat H; Fazli L; Jackson JK; Gleave ME
Urol Oncol; 2021 Mar; 39(3):194.e1-194.e7. PubMed ID: 33250343
[TBL] [Abstract] [Full Text] [Related]
[Next]
